Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate

US Patent 11938217 · Granted Mar 26, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical compositions of nilotinib2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2025
Stable liquid compositions of netupitant and palonosetron2025
Stable liquid compositions of netupitant and palonosetron2025
Stable liquid compositions of netupitant and palonosetron2025
Pharmaceutical liquid compositions of meloxicam2025
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2024
Ready-to-use injectable pharmaceutical compositions comprising neostigmine and g2024